about
Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapyThe tell-tale heart: molecular and cellular responses to childhood anthracycline exposureModeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-CardiomyocytesEffect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study--A Single-Center, Blinded, Randomized Controlled Trial.Introducing a new entity: chemotherapy-induced arrhythmia.Anthracycline Chemotherapy and Cardiotoxicity.Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes.Antineoplastic drug-induced bradyarrhythmias.Complete heart block in a patient with acute lymphoblastic leukaemia: teicoplanin as a possible cause and review of literature.Cancer chemotherapy and cardiac arrhythmias: a review.Arrhythmias and Other Electrophysiology Issues in Cancer Patients Receiving Chemotherapy or Radiation.Electrophysiological effects of anthracyclines in adult survivors of pediatric malignancy.Is screening for abnormal ECG patterns justified in long-term follow-up of childhood cancer survivors treated with anthracyclines?Remodeling of ventricular repolarization in a chronic doxorubicin cardiotoxicity rat model.Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma.Doxorubicin-induced changes of ventricular repolarization heterogeneity: results of a chronic rat study.Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies.Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms
P2860
Q24240568-277DE5A0-252B-4C6A-92FB-2013E0A18E44Q26823592-616258D6-44BA-4197-9ECB-86180AD7178AQ36864827-0BCDC29E-0810-4BBA-BAC6-E0C94F1C9CCAQ36894836-311EEB72-9BF6-468E-AA23-C1647F4BF086Q37607920-A5939795-7E0D-488B-AEBF-8A45B3902E4AQ37694541-0569392E-6C55-4ED8-937A-10DE98A567C1Q37704467-A5CBBB33-69A4-4961-8409-4649B22536EFQ38025714-814F499B-7FA6-435E-B433-B1FD46E48B6AQ38070722-3A39ED8A-4446-4A5F-AB21-979BCCA37F6CQ38313870-C4CBFC71-6F3F-41CE-84C5-74A55ADD5B8FQ38815946-E61E36FA-622E-4323-8BBD-4224D95324BAQ39270153-4D565584-1DDB-4AE8-A5C7-4806A6300C68Q39365954-4D2CD096-3A32-4CC3-877A-973A47186C37Q43589125-1FBD25C6-F896-47BF-858E-C71C824D1CDDQ46642466-99711F49-49C4-43CE-BECE-32CCE986E6FAQ47726932-4561A801-80E1-4D53-9DF0-B81ACF6F308EQ48222615-E0D2A255-5DE8-455A-8162-36DACF5C12D8Q49909927-31F20E5B-15AB-4F68-A58A-C50395DA1735Q58554222-B974C9A9-949C-43D7-8A90-32D06F408ABE
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Early and late arrhythmogenic effects of doxorubicin.
@ast
Early and late arrhythmogenic effects of doxorubicin.
@en
type
label
Early and late arrhythmogenic effects of doxorubicin.
@ast
Early and late arrhythmogenic effects of doxorubicin.
@en
prefLabel
Early and late arrhythmogenic effects of doxorubicin.
@ast
Early and late arrhythmogenic effects of doxorubicin.
@en
P2093
P1476
Early and late arrhythmogenic effects of doxorubicin.
@en
P2093
Ebru Akgul
Gulten Tekuzman
Ibrahim Barista
Kudret Aytemir
Saadettin Kilickap
Sercan Aksoy
P304
P356
10.1097/01.SMJ.0000257382.89910.FE
P407
P577
2007-03-01T00:00:00Z